Location History:
- Quebec, CA (2012 - 2017)
- Beaconsfield, CA (2011 - 2019)
Company Filing History:
9 out of 19 
3 out of 14 
2 out of 440 
Years Active: 2011-2019
Title: Roy Rabindranauth Sooknanan: Innovator in Biotherapeutics
Introduction
Roy Rabindranauth Sooknanan is a distinguished inventor based in Beaconsfield, Canada. He has made significant contributions to the field of biotherapeutics, holding a total of 16 patents. His work focuses on innovative methods and compositions that address critical health issues, particularly in bone remodeling and RNA isolation.
Latest Patents
One of Sooknanan's latest patents is titled "Methods of impairing osteoclast differentiation using antibodies that bind siglec-15." This invention relates to unique genetic polynucleotides involved in bone remodeling. It includes variants and derivatives of these polynucleotides and corresponding polypeptides, as well as methods for ameliorating symptoms caused by bone remodeling disorders. Another notable patent is for "Methods, compositions, and kits for generating rRNA-depleted samples or isolating rRNA from samples." This invention provides methods and compositions for generating rRNA-depleted samples and isolating rRNA from various samples, utilizing affinity-tagged antisense rRNA molecules.
Career Highlights
Throughout his career, Sooknanan has worked with several prominent companies, including Alethia Biotherapeutics Inc. and Cellscript, LLC. His expertise in biotherapeutics has allowed him to develop innovative solutions that have the potential to impact medical research and treatment.
Collaborations
Sooknanan has collaborated with notable professionals in his field, including Gilles Bernard Tremblay and Mario Filion. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Roy Rabindranauth Sooknanan is a prominent inventor whose work in biotherapeutics has led to significant advancements in the understanding and treatment of bone remodeling disorders. His innovative patents and collaborations highlight his commitment to improving health outcomes through scientific research.